CN1186020C - 用于提高突触应答的酰基苯并噁嗪 - Google Patents

用于提高突触应答的酰基苯并噁嗪 Download PDF

Info

Publication number
CN1186020C
CN1186020C CNB998046949A CN99804694A CN1186020C CN 1186020 C CN1186020 C CN 1186020C CN B998046949 A CNB998046949 A CN B998046949A CN 99804694 A CN99804694 A CN 99804694A CN 1186020 C CN1186020 C CN 1186020C
Authority
CN
China
Prior art keywords
alkyl
chemical compound
aralkyl
heteroarylalkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998046949A
Other languages
English (en)
Chinese (zh)
Other versions
CN1306427A (zh
Inventor
加里·A·罗杰斯
彼得·约翰斯特罗姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of CN1306427A publication Critical patent/CN1306427A/zh
Application granted granted Critical
Publication of CN1186020C publication Critical patent/CN1186020C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CNB998046949A 1998-04-03 1999-04-02 用于提高突触应答的酰基苯并噁嗪 Expired - Fee Related CN1186020C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/054,916 US6124278A (en) 1998-04-03 1998-04-03 Acylbenzoxazines for enhancing synaptic response
US09/054,916 1998-04-03

Publications (2)

Publication Number Publication Date
CN1306427A CN1306427A (zh) 2001-08-01
CN1186020C true CN1186020C (zh) 2005-01-26

Family

ID=21994357

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998046949A Expired - Fee Related CN1186020C (zh) 1998-04-03 1999-04-02 用于提高突触应答的酰基苯并噁嗪

Country Status (22)

Country Link
US (1) US6124278A (pt)
EP (1) EP1067935B1 (pt)
JP (1) JP4574846B2 (pt)
KR (1) KR100646753B1 (pt)
CN (1) CN1186020C (pt)
AT (1) ATE247472T1 (pt)
BR (1) BR9909378A (pt)
CA (1) CA2326764C (pt)
CZ (1) CZ292931B6 (pt)
DE (1) DE69910552T2 (pt)
DK (1) DK1067935T3 (pt)
ES (1) ES2207194T3 (pt)
HK (1) HK1039060B (pt)
HU (1) HUP0102321A3 (pt)
IL (1) IL138284A0 (pt)
NO (1) NO20004383L (pt)
NZ (1) NZ506712A (pt)
PL (1) PL195394B1 (pt)
PT (1) PT1067935E (pt)
RU (1) RU2246498C2 (pt)
TR (1) TR200002849T2 (pt)
WO (1) WO1999051240A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
HUP0400196A3 (en) 2001-06-14 2007-05-02 Organon Nv (pyrido/thieno)[f]oxazepin-5-one derivatives, their use and pharmaceutical compositions containing them
MXPA04004815A (es) * 2001-11-26 2005-02-17 Cortex Pharma Inc Compuestos de carbonilbenzoxazina para mejorar respuestas sinapticas, glutamatergicas.
EP2173369A2 (en) * 2003-08-08 2010-04-14 DSM IP Assets B.V. Novel method for screening brain-active compounds
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
CL2008000119A1 (es) 2007-01-16 2008-05-16 Wyeth Corp Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
JP5531011B2 (ja) * 2008-06-06 2014-06-25 サノフイ ＴＡＦＩａの阻害剤としての大環状尿素およびスルファミド誘導体
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
BR112015031249A2 (pt) 2013-06-13 2017-07-25 Veroscience Llc método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica
CN108689876B (zh) * 2018-06-28 2020-11-27 苏州东南药业股份有限公司 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
ATE253909T1 (de) * 1992-07-24 2003-11-15 Univ California Arzneimittel die den durch ampa rezeptoren vermittelten synaptischen response erhöhen
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response

Also Published As

Publication number Publication date
HK1039060A1 (en) 2002-04-12
BR9909378A (pt) 2000-12-05
HUP0102321A2 (hu) 2001-11-28
NO20004383D0 (no) 2000-09-04
ES2207194T3 (es) 2004-05-16
ATE247472T1 (de) 2003-09-15
WO1999051240A8 (en) 2001-03-22
HUP0102321A3 (en) 2002-01-28
DK1067935T3 (da) 2003-11-24
AU3379899A (en) 1999-10-25
NO20004383L (no) 2000-10-09
CZ20003614A3 (cs) 2001-01-17
WO1999051240A1 (en) 1999-10-14
JP2002510635A (ja) 2002-04-09
CA2326764C (en) 2010-12-14
NZ506712A (en) 2002-11-26
JP4574846B2 (ja) 2010-11-04
KR20010042192A (ko) 2001-05-25
US6124278A (en) 2000-09-26
CZ292931B6 (cs) 2004-01-14
KR100646753B1 (ko) 2006-11-17
EP1067935A1 (en) 2001-01-17
DE69910552D1 (de) 2003-09-25
IL138284A0 (en) 2001-10-31
EP1067935A4 (en) 2001-10-04
PL345687A1 (en) 2002-01-02
DE69910552T2 (de) 2004-06-17
EP1067935B1 (en) 2003-08-20
CN1306427A (zh) 2001-08-01
PT1067935E (pt) 2004-01-30
PL195394B1 (pl) 2007-09-28
HK1039060B (zh) 2005-05-13
TR200002849T2 (tr) 2001-06-21
RU2246498C2 (ru) 2005-02-20
AU736376B2 (en) 2001-07-26
CA2326764A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
AU708212B2 (en) Benzoxazines for enhancing synaptic response
AU688271B2 (en) Drugs that enhance synaptic responses mediated by ampa receptors
WO1997036907A9 (en) Benzoxazines for enhancing synaptic response
CN1085206C (zh) 可以增强ampa受体活性的苯并呋咱化合物
EP2187888B1 (en) Bicyclic amides for enhancing glutamatergic synaptic responses
CN1160360C (zh) 用于增强突触应答的氧氮杂萘化合物
CN1186020C (zh) 用于提高突触应答的酰基苯并噁嗪
CA2674460C (en) 3-substituted-h.2.31-benzotriazinone compound for enhancing glutamatergic synaptic responses
CN101801939A (zh) 用于增强谷氨酸能突触反应的3-取代1,2,3-三嗪-4-酮类和3-取代1,3-嘧啶酮类
CA2249654C (en) Benzoxazines for enhancing synaptic response
MXPA00009480A (en) Acylbenzoxazines for enhancing synaptic response(s)
US20020055498A1 (en) Benzofurazan compounds for enhancing glutamatergic synaptic responses
AU4454399A (en) Benzoxazines for enhancing synaptic response

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050126

Termination date: 20120402